ExodusPoint Capital Management’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
IA
MCI
HNB
ExodusPoint Capital Management's AMED Position: Q3 2025 in Review
ExodusPoint Capital Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 3,612 shares — an estimated $355K sold.
ExodusPoint Capital Management first reported a position in AMED in Q2 2020 and held it in 12 quarters. The position peaked at $6.5M in Q2 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- ExodusPoint Capital Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- ExodusPoint Capital Management sold 3,612 Amedisys shares in Q3 2025, an estimated $355K.
- ExodusPoint Capital Management first reported a position in Amedisys in Q2 2020 and held it in 12 quarters.
- ExodusPoint Capital Management's Amedisys position peaked at $6.5M in Q2 2020.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on ExodusPoint Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.